Ping Wu
Jiangsu University(CN)Huazhong Agricultural University(CN)Wenzhou Medical University(CN)PDL BioPharma (United States)(US)
Publications by Year
Research Areas
Gastroesophageal reflux and treatments, Glycosylation and Glycoproteins Research, Melanoma and MAPK Pathways, Sperm and Testicular Function, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China(2020)1,279 cited
- → B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies(2011)1,028 cited
- → Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients(2020)381 cited
- → Antagonists Induce a Conformational Change in cIAP1 That Promotes Autoubiquitination(2011)226 cited
- → Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer(2011)215 cited
- → SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1(2021)